Search by Drug Name or NDC
NDC 59088-0786-31 LiquiCal with Magnesium 168; 66; 48; 1.4 mg/mL; [iU]/mL; mg/mL; mg/mL Details
LiquiCal with Magnesium 168; 66; 48; 1.4 mg/mL; [iU]/mL; mg/mL; mg/mL
LiquiCal with Magnesium is a ORAL LIQUID in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PureTek Corporation. The primary component is CALCIUM CITRATE; CHOLECALCIFEROL; MAGNESIUM CITRATE; ZINC CITRATE.
Product Information
| NDC | 59088-0786 |
|---|---|
| Product ID | 59088-786_0d0f04ad-5b77-49d8-e063-6394a90a99e1 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | LiquiCal with Magnesium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Multivitamin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | LIQUID |
| Route | ORAL |
| Active Ingredient Strength | 168; 66; 48; 1.4 |
| Active Ingredient Units | mg/mL; [iU]/mL; mg/mL; mg/mL |
| Substance Name | CALCIUM CITRATE; CHOLECALCIFEROL; MAGNESIUM CITRATE; ZINC CITRATE |
| Labeler Name | PureTek Corporation |
| Pharmaceutical Class | Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 59088-0786-31 (59088078631)
| NDC Package Code | 59088-786-31 |
|---|---|
| Billing NDC | 59088078631 |
| Package | 480 mL in 1 BOTTLE (59088-786-31) |
| Marketing Start Date | 2023-12-27 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |